Cite
Papakonstantinou VD, Lagopati N, Tsilibary EC, et al. A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?. Bioinorg Chem Appl. 2017;2017:6947034doi: 10.1155/2017/6947034.
Papakonstantinou, V. D., Lagopati, N., Tsilibary, E. C., Demopoulos, C. A., & Philippopoulos, A. I. (2017). A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?. Bioinorganic chemistry and applications, 20176947034. https://doi.org/10.1155/2017/6947034
Papakonstantinou, Vasiliki D, et al. "A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?." Bioinorganic chemistry and applications vol. 2017 (2017): 6947034. doi: https://doi.org/10.1155/2017/6947034
Papakonstantinou VD, Lagopati N, Tsilibary EC, Demopoulos CA, Philippopoulos AI. A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?. Bioinorg Chem Appl. 2017;2017:6947034. doi: 10.1155/2017/6947034. Epub 2017 Mar 28. PMID: 28458618; PMCID: PMC5387815.
Copy
Download .nbib